spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Prometic Bioseparations are very pleased to introduce their new purpose built ecommerce platform (Webshop)!


Their goal was to build a platform that is easy to navigate, informative and one that makes their products and services easily accessible to researchers and laboratories worldwide. They also wanted to make ordering as quick and easy as possible to meet the needs of the rapidly progressive industry. They have reflected these requirements with an ecommerce store in order to supply high quality products to customers from academia to big pharma.

They look forward to welcoming you to the new online store at www.prometicbioseparations.com/products2525 and continue working together.

To make your first visit even more productive they are offering a free prepacked Ion Exchange column with the first 100 orders. To claim your free column simply e-mail sales-pbl@prometic.com with your order number, name and address along with your choice from Q, SP, DEAE and CM PuraBead HF column.

 
Print this page
Send to a friend
   
spacer
News and Press Releases

New to the PPMA Show 2018: Bright Ideas - Ambassador Programme

A new initiative for PPMA Show visitors this year is the Bright Ideas - Ambassador Programme - a free advice service for start-up ventures and entrepreneurs.
More info >>


White Papers

Managing GxP Environmental Systems to Ensure Data Integrity

Vaisala Ltd


More info >>

Industry Events

SMI Immuno-Oncology Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement